StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead (GILD) PT Drops to $87 at Baird on 2017 Guidance
February 8, 2017 6:19 AM
Baird analyst Brian Skorney maintains Outperform rating, but lowers price target on Gilead Sciences (NASDAQ: GILD) to $87 (from $100) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Gild Sciences (GILD) PT Drops to $75 at BMO on Bad Guidance
February 9, 2017 6:41 AM
Gilead Sciences (GILD): 'Acquisition Wanted! - Please Apply Within'
February 8, 2017 11:09 AM
Gilead Sciences (GILD) Pressured on Market Open, Shares Down 10%
February 8, 2017 9:40 AM
Needham & Company Remains Sidelined on Gilead Sciences (GILD) Following 4Q
February 8, 2017 6:57 AM
Piper Jaffray On Gilead (GILD) - It Stinks But If You Hold Your Nose It's Not That Bad
February 8, 2017 6:12 AM
Gilead Sciences (GILD) PT Lowered to $79 at Credit Suisse, Says M&A Is Upside Driver From Here
February 8, 2017 5:01 AM
Welsl Fargo Lowering PT Range On Gilead (GILD)
February 8, 2017 5:00 AM
Gilead Sciences (GILD) PT Lowered to $77 at Morgan Stanley
February 8, 2017 4:29 AM
Citi Downgrades Gilead Sciences (GILD) to Neutral
February 8, 2017 4:19 AM
Gilead Sciences (GILD) Raises Quarterly Dividend 10.6% to $0.52; 2.8% Yield
February 7, 2017 4:03 PM
Gilead Sciences (GILD) Tops Q4 EPS by 9c, Offers FY17 Guidance
February 7, 2017 4:03 PM
Gilead Sciences Announces 10 Percent Increase in First Quarter 2017 Dividend
February 7, 2017 4:02 PM
